My bookmarksSign up free

Commission Delegated Regulation (EU) 2017/751 of 16 March 2017 amending Delegated Regulations (EU) 2015/2205, (EU) 2016/592 and (EU) 2016/1178 as regards the deadline for compliance with clearing obligations for certain counterparties dealing with OTC derivatives (Text with EEA relevance. )

Commission Delegated Regulation (EU) 2017/751 of 16 March 2017 amending Delegated Regulations (EU) 2015/2205, (EU) 2016/592 and (EU) 2016/1178 as regards the deadline for compliance with clearing obligations for certain counterparties dealing with OTC derivatives (Text with EEA relevance. )

Delegated Regulation (EU) 2017/751 Β· Regulation Β· 4 articles

Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β†—

Amendment to Delegated Regulation (EU) 2015/2205

Article 1

In Article 3(1) of Delegated Regulation (EU) 2015/2205, point (c) is replaced by the following: β€˜(c) 21 June 2019 for counterparties in Category 3;’.

Amendment to Delegated Regulation (EU) 2016/592

Article 2

In Article 3(1) of Delegated Regulation (EU) 2016/592, point (c) is replaced by the following: β€˜(c) 21 June 2019 for counterparties in Category 3;’.

Amendment to Delegated Regulation (EU) 2016/1178

Article 3

In Article 3(1) of Delegated Regulation (EU) 2016/1178, point (c) is replaced by the following: β€˜(c) 21 June 2019 for counterparties in Category 3;’.

Entry into force

Article 4

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next